Pathway to the Clinic: Inhibition of P38 MAP Kinase. A Review of Ten Chemotypes Selected for Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|5|10|1017-1029

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.5, Iss.10, 2005-09, pp. : 1017-1029

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Discovery of Novel Chemotypes of p38 Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. : 953-965

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Inflammation by a p38 MAP Kinase Targeted Cell Permeable Peptide

By  

Medicinal Chemistry, Vol. 4, Iss. 6, 2008-11 ,pp. : 597-604

Bentham Science Publishers

Access to resources Recommend Favorite

Pyridinylimidazole Based p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

Naloxone Inhibition of Lipopolysaccharide-induced Activation of Retinal Microglia is Partly Mediated via the p38 Mitogen Activated Protein Kinase Signalling Pathway

By Xu YF   Fu Ll   Jiang CH   Qin YW   Ni YQ   Fan JW  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1438-1448

Field House Publishing

Access to resources Recommend Favorite

The Non-Diaryl Heterocycle Classes of p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1021-1035

Bentham Science Publishers

Access to resources Recommend Favorite